Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Chinese raw materials companies are cozying up with battery makers in Morocco and South Korea as a way of bypassing US restrictions.
ExxonMobil announced it will purchase Pioneer Natural Resources for just under $60 billion, marking the largest oil-and-gas deal in decades.
Amazon’s October Prime sales event wrapped up Tuesday, and this year saw a massive shift in consumer behavior.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Home Depot cracked open a crime ring that has accounted for $3 million in stolen goods across its Florida locations.
The tech could help Ford – and those that buy Ford’s industrial fleet vehicles – cut their emissions by keeping a closer eye on them.
Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Blue Origin is expected to back out of plans to build a commercial space station in conjunction with corporate partners.
On Monday, Rivian announced an expectations-beating jump in deliveries for its third quarter. But a new report says it’s still losing money.
In an interview with Bloomberg, CEO Brian Chesky laid out how Airbnb has been rocked by user dissatisfaction and tighter regulation.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.